Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones

DOI: 10.1248/cpb.32.2773

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2565 - 2570 (1984)

Update date:2022-09-26

Topics:

Authors:

Akimoto Akimoto

Kawai Kawai

Hashimoto

Nomura Nomura

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.32.2773

Full text of DOI:10.1248/cpb.32.2773

NII-Electronic Library Service

Products guided by the article

Product name:3-epimaytansinol 3-phenylacetate

Cas No:72887-70-8

R&D Labs maybe for 72887-70-8

Anhui Biochem United Pharmaceutical Co., Ltd.

Contact:0086 551 5167062 / 5228268

Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Shanghai HengXun Pharmaceutical Tech. Co., Ltd.

Contact:86-86-52730756

Address:Room 603, No. 240, Tianmuzhong Road, Zhabei, Shanghai, China
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd

Contact:+86-517-86283327

Address:9 North Hantai Road, Huaian, China
Zhaodu Fine Chemical Plant

Contact:86-310-8067016

Address:East Fuhua Road,Tiexi Chemical Industrial Estate,Hebei,China
Wuxi Forest Biological Co.,Ltd

Contact:+86-510-81602300

Address:Room 317,Building D, No.159 middle Chengjiang Road,Jiangyin Wuxi city.

Relevant to this article

DABCO-mediated decarboxylative cyclization of isatoic anhydride with aroyl/heteroaroyl/alkoylacetonitriles under microwave conditions: Strategy for the synthesis of substituted 4-quinolones

Doi:10.1016/j.tetlet.2021.153187
(2021)
Site- And enantiodifferentiating C(sp³)-H oxidation enables asymmetric access to structurally and stereochemically diverse saturated cyclic ethers

Doi:10.1021/jacs.0c09636
(2020)
Doi:10.1021/jo01017a020
(1965)
ACID-CATALYSED MONOACETYLATION OF TWO 3-DEOXYHEXITOLS

Doi:10.1016/0008-6215(80)90004-X
(1980)
Development of a Strategy for Convergent Total Synthesis of the Aureolic Acid Antitumor Antibiotics

Doi:10.1021/jo00142a009
(1982)
Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: Discovery of deleobuvir (BI 207127)

Doi:10.1021/jm4011862
(2014)

Article Doi